Le Lézard
Classified in: Environment, Health
Subjects: ENI, CFG

RNAO urges Canadians to inform themselves on major health, social and environmental issues ahead of Oct. 21 vote

TORONTO, Oct. 16, 2019 /CNW/ - As the federal election campaign enters its final days, registered nurses (RN), nurse practitioners (NP) and nursing students in Ontario are calling on Canadians to cast an informed vote.

Polls show the major parties are in a tight race, jockeying for position as the countdown to Oct. 21 approaches. To help voters make a choice that reflects the federal government's key role in shaping health and health-care policy, the Registered Nurses' Association of Ontario (RNAO) is inviting voters to look at its platform of recommendations on access to care, social determinants of health, the environment and fiscal capacity.

A platform for a healthy Canada offers evidence-based policies important to nurses and to Canadians ? including a universal pharmacare plan, action on the opioid crisis, addressing long-standing inequality and discrimination faced by Indigenous People, substantive measures to tackle climate change, and reinstating the role of a national chief nursing officer. Three parties committed to this latter ask.

"I don't think we've seen an election this close in recent memory and that means every single vote will be crucial in determining the future direction of Canada," says RNAO president Dr. Angela Cooper Brathwaite. "And that's why it is essential voters consider each party's election promises and weigh them against the issues they believe will advance the health of Canadians."

To help voters, RNAO sent each of the major parties a questionnaire, inviting them to respond to the association's recommendations. The only party that did not respond was the Conservative Party of Canada.

"Health care may be administered by the provinces, but keeping Canadians healthy is something that requires strong federal leadership. We need a federal government that advances social and environmental determinants and that is committed to paying its fair share of health expenditures," says RNAO's CEO Dr. Doris Grinspun. "The goal of nurses is to keep people healthy and care for them when they are ill. For this, people need an adequate roof over their heads, clean air to breathe, and affordable medications. Candidates that understand this deserve our vote," she adds.

Canadians can find out where and how to vote by visiting the Elections Canada website.

RNAO is the professional association representing registered nurses, nurse practitioners, and nursing students in Ontario. Since 1925, RNAO has advocated for healthy public policy, promoted excellence in nursing practice, increased nurses' contribution to shaping the health system, and influenced decisions that affect nurses and the public they serve. For more information about RNAO, visit RNAO.ca or follow us on Facebook and Twitter.

SOURCE Registered Nurses' Association of Ontario

These press releases may also interest you

at 04:56
kneat.com, inc. ("Kneat"), announces that the Company will release its Financial Results for the quarter ended March 31, 2020 after TSX market close on Wednesday 27 May 2020. ...

at 04:35
The global tissue engineering market size is expected to reach USD 28.9 billion by 2027, expanding at a CAGR of 14.2%, according to a new report by Grand View Research, Inc. Allogenic tissue transplant method efficiently addresses challenges and...

at 04:23
Enzymatica and its partner STADA have extended its agreement for the cold spray ViruProtect® (ColdZyme) to cover another 19 countries in Europe. With the extended agreement STADA has provided order estimates of about SEK 20 million for 2020. The...

at 04:00
As governments in many countries are easing lockdown restrictions, fitness facilities are getting ready to re-open and welcome back customers. After the pandemic, health has certainly risen to the top of the list of consumers' personal priorities,...

at 03:30
The "Global Molecular Point of Care (mPOC) Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The molecular point of care (mPOC) devices market is poised to grow by $ 816.62 million during 2020-2024 progressing at...

at 03:25
Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the ongoing EMA review of imlifidase for a potential marketing authorization in Europe is on track. A CHMP opinion is expected at...

News published on 16 october 2019 at 10:50 and distributed by: